GSK plc ( GLAXF) - Key Metrics
GLAXF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.14 | $0.16 | $0.52 | $0.38 |
| 2025Q3 | $2.12 | $0.50 | $0.55 | $0.33 |
| 2025Q2 | $1.97 | $0.36 | $0.52 | $0.36 |
| 2025Q1 | $1.84 | $0.40 | $0.28 | $0.17 |
GLAXF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 101.57% | 28.82 |
| 2025Q3 | 32.29% | 7.89 |
| 2025Q2 | 45.46% | 9.78 |
| 2025Q1 | 37.68% | 9.20 |
GLAXF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.84% | ? |
| 2025Q4 | 2.07% | 0.88% |
| 2025Q3 | 4.15% | 1.02% |
| 2025Q2 | 2.65% | 1.16% |
| 2025Q1 | 1.12% | 1.02% |
GLAXF
Price: $25.31
Dividend Yield: 3.48%
Payout Ratio: 51.48%
Earnings Per Share: 1.93 USD
P/E Ratio: 12.96
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Market Capitalization: 103.3 billion
Average Dividend Frequency: 8
Years Paying Dividends: 23
DGR3: 11.79%
DGR5: 7.08%
DGR10: 1.30%
DGR20: 5.77%